Wedbush Reiterates Outperform on Generation Bio, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten reiterates an Outperform rating on Generation Bio (NASDAQ:GBIO) and maintains a $5 price target.
May 14, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst David Nierengarten reaffirmed an Outperform rating on Generation Bio, with a continued price target of $5, indicating a positive outlook on the company's stock.
Analyst ratings, especially those with a positive outlook such as an Outperform rating, can influence investor sentiment and potentially lead to an increase in stock price. Maintaining a price target suggests confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100